The Value of Circulating microRNAs for Diagnosis and Prediction of Preeclampsia: a Meta-analysis and Systematic Review

• Published in: Reproductive sciences (Thousand Oaks, Calif.) Vol. 29; no. 11; pp. 3078 - 3090
• Main Authors: Qin, Shiting, Sun, Ningxia, Xu, Longqiang, Xu, Yinglei, Tang, Qian, Tan, Lijuan, Chen, Aiping, Zhang, Lu, Liu, Shiguo
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.11.2022
• Subjects: Embryology; Medicine; Medicine & Public Health; Obstetrics/Perinatology/Midwifery; Reproductive Medicine; Review; Biomarkers; Sensitivity; Specificity; Preeclampsia; MicroRNAs; Meta-analysis
• ISSN: 1933-7191; 1933-7205
• DOI: 10.1007/s43032-021-00799-6

Preeclampsia (PE) is one of the main causes of maternal death worldwide, but our understanding of the molecular characteristics of disease progression is limited. In this meta-analysis, we aimed to assess the value of peripheral blood microRNAs (miRNAs) as diagnostic and predictive markers of PE. We screened PubMed, Web of Science, and Embase databases; searched articles about “miRNAs and PE” up to November 30, 2020; and conducted biological information and subgroup analysis. We used QUADAS-2 (quality assessment of diagnostic accuracy studies-2) to evaluate the included articles by two independent reviewers, calculated the combined diagnostic and predictive indicators using the random effects model, explored the sources of potential heterogeneity through subgroup analysis, and evaluated publication bias using Deeks’ funnel plot asymmetry test using Stata 14.0 and Review Manager 5.3 software. Forty-three miRNAs from 15 studies, including 2042 healthy controls and 2685 PE patients, had a pooled sensitivity of 0.86 (95% CI: 0.81–0.90), specificity of 0.89 (95% CI: 0.85–0.92), and an AUC of 0.94 (95% CI: 0.91–0.96). Moreover, before 20 weeks of gestation, the combined sensitivity was 0.86 (95% CI: 0.75–0.92), and the specificity was 0.90 (95% CI: 0.83–0.95), which indicated that some of the circulating miRNAs had changed significantly before the clinical symptoms appeared in PE patients. Circulating miRNAs have high diagnostic and predictive accuracy and may be used as non-invasive biomarkers for the diagnosis and prediction of PE. However, a large sample prospective study is still needed.